A Canadian study recently assessed 709 patients with intermediate- and high-risk synchronous mRCC with or without sarcomatoid features. Most patients had clear cell histology and were treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback